Baidu
map
CLIN MED INSIGHTS-EN 润色咨询

Clinical Medicine Insights-Endocrinology and Diabetes

出版年份：暂无数据 年文章数：116 投稿命中率： 开通期刊会员，数据随心看

出版周期：annual 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2229722, encodeId=3a832229e225d, content=偏重的研究方向：脂肪肝<br>经验分享：投了一篇，半年内见刊，编辑回复都挺及时的，版面费授权中国进出口出版集团，交起来也很方便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e57110015, createdName=babygo, createdTime=Tue Oct 08 09:16:45 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178718, encodeId=cd1321e871875, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：之前投过一篇case report，约1个半月后直接接收，这期刊前景感觉还挺不错，而且据说最近还在增加在中国地区的收稿量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Tue Jan 02 09:39:20 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177824, encodeId=364c21e782414, content=师兄之前投投过，最近还首获影响因子2.8，我也考虑在这投搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Thu Dec 28 16:57:40 CST 2023, time=2023-12-28, status=1, ipAttribution=上海)]
    2024-10-08 babygo 来自江苏省

    偏重的研究方向：脂肪肝
    经验分享：投了一篇，半年内见刊，编辑回复都挺及时的，版面费授权中国进出口出版集团，交起来也很方便

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2229722, encodeId=3a832229e225d, content=偏重的研究方向：脂肪肝<br>经验分享：投了一篇，半年内见刊，编辑回复都挺及时的，版面费授权中国进出口出版集团，交起来也很方便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e57110015, createdName=babygo, createdTime=Tue Oct 08 09:16:45 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178718, encodeId=cd1321e871875, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：之前投过一篇case report，约1个半月后直接接收，这期刊前景感觉还挺不错，而且据说最近还在增加在中国地区的收稿量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Tue Jan 02 09:39:20 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177824, encodeId=364c21e782414, content=师兄之前投投过，最近还首获影响因子2.8，我也考虑在这投搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Thu Dec 28 16:57:40 CST 2023, time=2023-12-28, status=1, ipAttribution=上海)]
    2024-01-02 ms66265655 来自上海

    审稿速度:2.0 | 投稿命中率:95.0
    经验分享：之前投过一篇case report，约1个半月后直接接收，这期刊前景感觉还挺不错，而且据说最近还在增加在中国地区的收稿量

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2229722, encodeId=3a832229e225d, content=偏重的研究方向：脂肪肝<br>经验分享：投了一篇，半年内见刊，编辑回复都挺及时的，版面费授权中国进出口出版集团，交起来也很方便, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5e57110015, createdName=babygo, createdTime=Tue Oct 08 09:16:45 CST 2024, time=2024-10-08, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178718, encodeId=cd1321e871875, content=审稿速度:2.0 | 投稿命中率:95.0<br>经验分享：之前投过一篇case report，约1个半月后直接接收，这期刊前景感觉还挺不错，而且据说最近还在增加在中国地区的收稿量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcc96407078, createdName=ms66265655, createdTime=Tue Jan 02 09:39:20 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2177824, encodeId=364c21e782414, content=师兄之前投投过，最近还首获影响因子2.8，我也考虑在这投搞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Thu Dec 28 16:57:40 CST 2023, time=2023-12-28, status=1, ipAttribution=上海)]
    2023-12-28 小动量 来自上海

    师兄之前投投过，最近还首获影响因子2.8，我也考虑在这投搞

    0

共3条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map